SCHEDULE 13D

Company

GeneDx Holdings Corp.

Filed

August 2, 2021

Accession Number

0001213900-21-039855

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →